Resmed (RSMDF) Total Debt (2010 - 2026)

Resmed (RSMDF) has reported Total Debt for 17 consecutive years, with $919.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt rose 35.55% year-over-year to $919.3 million; the trailing twelve-month figure through Jun 2026 stood at $919.3 million (up 35.55% YoY), and the FY2026 full-year result was $919.3 million, up 35.55% from the prior year.
• Total Debt retreated to $919.3 million in Q2 2026 per RSMDF's latest filing, from $924.0 million in the prior quarter.
• Across five years, Total Debt topped out at $1.8 billion in Q4 2022 and bottomed at $678.2 million in Q2 2025.
• Historically, Total Debt has averaged $994.9 million across 5 years, with a median of $921.5 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Total Debt surged 161.64% in 2022, then slumped 50.58% in 2024.
• Over 5 years, Total Debt stood at $1.8 billion in 2022, then plunged by 31.7% to $1.2 billion in 2023, then slumped by 44.79% to $682.7 million in 2024, then surged by 35.31% to $923.7 million in 2025, then dropped by 0.48% to $919.3 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $919.3 million, $924.0 million, and $923.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.